Quest Diagnostics (DGX) Reports In-Line Q1 EPS; Reaffirms Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. WCN
6. SPOT
7. FIX
8. BE
9. BMY
10. PNFP

Go back to Quest Diagnostics (DGX) Reports In-Line Q1 EPS; Reaffirms Outlook

Mizuho Securities Raises Price Target on Quest Diagnostics (DGX) Following In-Line 1Q Results

April 21, 2016 2:16 PM EDT

Mizuho Securities reiterated an Outperform rating on Quest Diagnostics (NYSE: DGX), and raised the price target to $84.00 (from $75.00), following the company's 1Q earnings report. DGX reported an adjusted EPS of $1.12, in-line with consensus estimates.

Analyst Ann Hynes commented, "We are raising our price... More